This episode features Professor Rachel Elliott, who bridges pharmacy and economics to transform healthcare spending. Is the £1.2 trillion global pharmaceutical budget being used wisely? As one of the UK's first pharmacists trained in health economics, Rachel evaluates whether expensive treatments and technologies truly deliver value. With over 150 published papers and £58 million in research funding, she ensures healthcare financial decisions are evidence-based rather than assumption-driven. Join us to explore Rachel'sjourney from ICU pharmacy specialist to pioneering health economist, how she faced criticism that she "no longer cared for patients," her guidance for clinicians entering research, and her insights from chairing NIHR fellowship awards while navigating both clinical and academic worlds.

Ver todos los episodios